Gachon University Gil Hospital

A leading hospital in Korea implemented a business intelligence solution that reduces drug-related risks for patients by using analytics to provide more accurate information for physicians—and patients

Published on 29-Jun-2011

Validated on 28 Feb 2013

"Today, with so many drug therapies available and often so little face time with patients, even the most experienced doctors cannot fully and accurately assess the complex possibilities for adverse drug interactions. So having the ability to spot dangers is a game-changer for improving patient safety." - Dong Kyun Park, Director of U-Healthcare Center, Gachon University Gil Hospital

Customer:
Gachon University Gil Hospital

Industry:
Healthcare

Deployment country:
Korea - Republic of

Solution:
Database Management, Business Intelligence, IBM Research, Information Governance, Information Integration, Smarter Planet, Dynamic Infrastructure, Linux, Openness

Smarter Planet:
Smarter Healthcare

Overview

What if doctors could improve patient safety by lowering the risk of giving patients drugs that could, potentially, cause an adverse reaction?

Business need:
Gachon University Gil Hospital wanted an advanced clinical decision platform to assist its practitioners, help educate its patients and minimize the possibility of adverse drug events (ADEs), the fourth-leading cause of patient death worldwide. Sixty percent of ADE incidents result from a lack of drug or patient information.

Solution:
Gil Medical Center’s business intelligence system analyzes a detailed combination of drug and patient information to produce insights for physicians that are meaningful and extremely useful in lowering the risk of ADEs. The BI system combines ADE-related knowledge with patient-specific clinical data, like age, disease, and alcohol and drug-use history drawn from electronic medical records, personal health records, genomic services, sensor devices and other sources.

Benefits:
• Developed a platform that will support the low-cost implementation of new Knowledge Management functions, such as chronic disease management and clinical pathway monitoring • Provided clinicians, pharmacists and patients with much more accurate drug risk results than were previously available • Enables hospitals to dramatically improve patient safety by reducing the possibility of ADEs

Case Study

Founded in 1958 as an obstetrics and gynecology clinic, Gachon University Gil Hospital has grown to become one of Korea’s leading healthcare providers. Today, Gachon University Gil Hospital is a world-class center with more than 30 medical departments and specialized centers as well as an affiliated medical university and research institute. Gachon University Gil Hospital is headquartered in Incheon, Korea.

The Opportunity

Gachon University Gil Hospital wanted an advanced clinical decision platform to assist its practitioners, help educate its patients and minimize the possibility of adverse drug events (ADEs), the fourth-leading cause of patient death worldwide. Sixty percent of ADE incidents result from a lack of drug or patient information.

What Makes it Smarter

The last thing any healthcare provider wants is for actions designed to help a patient to actually have the opposite result. Gil Medical Center’s business intelligence system significantly decreases that possibility by helping to radically reduce the risk of adverse drug events. It analyzes a detailed combination of drug and patient information to produce insights for physicians that are meaningful and extremely useful in lowering the risk of ADEs. The BI system combines ADE-related knowledge with patient-specific clinical data, like age, disease, and alcohol and drug-use history drawn from electronic medical records, personal health records, genomic services, sensor devices and other sources.

Real Business Results

Developed a platform that will support the low-cost implementation of new Knowledge Management functions, such as chronic disease management and clinical pathway monitoring
Provided clinicians, pharmacists and patients with much more accurate drug risk results than were previously available
Enables hospitals to dramatically improve patient safety by reducing the possibility of ADEs

For more information

Please contact your IBM sales representative or IBM Business Partner. Visit us at: ibm.com/healthcare

To learn more about Gachon University Gil Hospital, visit: http://foreigner.gilhospital.com/

Products and services used

IBM products and services that were used in this case study.

Hardware:
System x: System x3500 M2

Software:
DB2 Enterprise 9, InfoSphere MashupHub, WebSphere Sensor Events, WebSphere Application Server, DB2 Enterprise Server Edition, IBM Mashup Center

Operating system:
Linux

Legal Information

© Copyright IBM Corporation 2011 IBM Corporation 1 New Orchard Road Armonk, NY 10504U.S.A. Produced in the United StatesJune 2011All Rights Reserved IBM, the IBM logo, ibm.com, DB2, InfoSphere, System x and WebSphere are trademarks of International Business Machines Corporation, registered in many jurisdictions worldwide. A current list of IBM trademarks is available on the Web at “Copyright and trademark information” at ibm.com/legal/copytrade.shtml Other company, product or service names may be trademarks or service marks of others. The information contained in this documentation is provided for informational purposes only. While efforts were made to verify the completeness and accuracy of the information contained in this documentation, it is provided “as is” without warranty of any kind, express or implied. In addition, this information is based on IBM’s current product plans and strategy, which are subject to change by IBM without notice. IBM shall not be responsible for any damages arising out of the use of, or otherwise related to, this documentation or any other documentation. Nothing contained in this documentation is intended to, nor shall have the effect of, creating any warranties or representations from IBM (or its suppliers or licensors), or altering the terms and conditions of the applicable license agreement governing the use of IBM software. WSC14293-USEN-00